Prognostic impact of chromosomal changes at relapse after allogeneic hematopoietic cell transplantation for acute myeloid leukemia or myelodysplastic syndrome

[1]  Hisashi Yamamoto,et al.  Prognostic impact of cytogenetic evolution on the outcome of allogeneic stem cell transplantation in patients with acute myeloid leukemia in non-remission: A single institute analysis of 212 recipients. , 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  J. Barlow,et al.  Fragile site instability: measuring more than breaks , 2020, Oncoscience.

[3]  I. Khvostunov,et al.  ACUTE MYELOID LEUKEMIA, PROSTATE AND SKIN CANCER IN ACUTE RADIATION SYNDROME SURVIVOR AFTER THE 1986 CHERNOBYL NUCLEAR ACCIDENT: CASE REPORT. , 2018, Radiation protection dosimetry.

[4]  H. Kosiorek,et al.  Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  Bob Löwenberg,et al.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.

[6]  M. Schmid,et al.  ISCN 2016: An International System for Human Cytogenomic Nomenclature (2016) , 2016 .

[7]  Nicola D. Roberts,et al.  Genomic Classification and Prognosis in Acute Myeloid Leukemia. , 2016, The New England journal of medicine.

[8]  D. Grimwade,et al.  Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. , 2016, Blood.

[9]  S. Fröhling,et al.  Preview : Published ahead of advance online publication Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia , 2015 .

[10]  M. Horowitz,et al.  Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. , 2014, Blood.

[11]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[12]  Luca Malcovati,et al.  Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.

[13]  Francesca Chiaromonte,et al.  A genome-wide analysis of common fragile sites: What features determine chromosomal instability in the human genome? , 2012, Genome research.

[14]  N. Socci,et al.  Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. , 2012, The New England journal of medicine.

[15]  C. Steidl,et al.  New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Joshua F. McMichael,et al.  Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.

[17]  Xingmin Feng,et al.  Graft-versus-host disease: role of inflammation in the development of chromosomal abnormalities of keratinocytes. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  T. Haferlach,et al.  Comparison of cytogenetic clonal evolution patterns following allogeneic hematopoietic transplantation versus conventional treatment in patients at relapse of AML. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[19]  E. Thiel,et al.  Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation. , 2010, Cancer genetics and cytogenetics.

[20]  B. Johansson,et al.  Cytogenetic evolution patterns in CML post-SCT , 2007, Bone Marrow Transplantation.

[21]  T. Glover,et al.  Common fragile sites as targets for chromosome rearrangements. , 2006, DNA repair.

[22]  S. Powell,et al.  Repair of radiation damage to DNA , 2004, British Journal of Cancer.

[23]  W. Hiddemann,et al.  Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy , 2002, Leukemia.

[24]  S. Asano,et al.  Transient hematopoietic stem cell rescue using umbilical cord blood for a lethally irradiated nuclear accident victim , 2002, Bone Marrow Transplantation.

[25]  K Wheatley,et al.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.

[26]  A. de la Chapelle,et al.  Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapse. , 1989, Cancer genetics and cytogenetics.

[27]  T. Sofuni,et al.  Relationship between the radiation dose and chromosome aberrations in atomic bomb survivors of Hiroshima and Nagasaki. , 1978, Journal of radiation research.

[28]  N. Kröger,et al.  Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[29]  L. Shaffer,et al.  ISCN 2009 - An International System for Human Cytogenetic Nomenclature , 2009 .

[30]  เอกรัฐ รัฐฤทธิ์ธำรง.  Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation , 2009 .

[31]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .